Richard J. Reimer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Richard J. Reimer has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- John R. Huguenard
Stanford University School of Medicine
4 shared publications Hiroaki Tani
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA
3 shared publications- Chris G. Dulla
Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, United States
2 shared publications Kimberly A. Zaia
Department of Neurology and Neurological Sciences and Neuroscience Graduate Program, Stanford University, Stanford, California 94305, USA
2 shared publicationsAmaro Taylor-Weiner
Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA
1 shared publication- Anita Bandrowski
Department of Neuroscience, University of California at San Diego, San Diego, California, USA
1 shared publication
Latest Publications
- Open Access
- 10 July 2021
- Published by Springer Nature in Cureus
- Vol. 13 (7)
Acute on Chronic Neuromuscular Respiratory Failure in the Intensive Care Unit: Optimization of Triage, Ventilation Modes, and Extubation
Critical care management of acute respiratory failure in patients with neuromuscular disease (NMD) such as amyotrophic lateral sclerosis (ALS) is not standardized and is challenging for many critical care specialists. Progressive hypercapnic respiratory failure and ineffective airway clearance are key issues in this patient population. Often at the time of hospital presentation, patients are already supported by home mechanical ventilatory support with noninvasive ventilation (NIV) and an airway clearance regimen. Prognosis is poor once a patient develops acute respiratory failure requiring intubation and invasive mechanical ventilatory support, commonly leading to tracheostomy or palliative-focused care. We focus on this understudied group of patients with ALS without tracheostomy and incorporate existing data to propose a technical approach to the triage and management of acute respiratory failure, primarily for those who require intubation and mechanical ventilatory support for reversible causes, and also for progression of end-stage disease. Optimizing management in this setting improves both quality and quantity of life. Neuromuscular patients with acute respiratory failure require protocolized and personalized triage and treatment. Here, we describe the technical methods used at our single institution. The triage phase incorporates comprehensive evaluation for new etiologies of hypoxia and hypercapnia, which are not initially presumed to be secondary to progression or end-stage neuromuscular respiratory failure. In select patients, this may involve intubation or advanced adjustments of NIV machines. Next, once the acute etiology(s) is identified and treated, the focus shifts: training and use of mechanical airway clearance to optimize pulmonary function, facilitation of NIV wean or successful extubation to NIV, and transition to a stable regimen for home ventilation. The comprehensive protocol described here incorporates multi institutional approaches and effectively optimizes acute respiratory failure in patients with neuromuscular pulmonary disease.
- 10 July 2021
- Published by Springer Nature in Cureus
- Vol. 13 (7)
Open AccessAcute on Chronic Neuromuscular Respiratory Failure in the Intensive Care Unit: Optimization of Triage, Ventilation Modes, and Extubation
Critical care management of acute respiratory failure in patients with neuromuscular disease (NMD) such as amyotrophic lateral sclerosis (ALS) is not standardized and is challenging for many critical care specialists. Progressive hypercapnic respiratory failure and ineffective airway clearance are key issues in this patient population. Often at the time of hospital presentation, patients are already supported by home mechanical ventilatory support with noninvasive ventilation (NIV) and an airway clearance regimen. Prognosis is poor once a patient develops acute respiratory failure requiring intubation and invasive mechanical ventilatory support, commonly leading to tracheostomy or palliative-focused care. We focus on this understudied group of patients with ALS without tracheostomy and incorporate existing data to propose a technical approach to the triage and management of acute respiratory failure, primarily for those who require intubation and mechanical ventilatory support for reversible causes, and also for progression of end-stage disease. Optimizing management in this setting improves both quality and quantity of life. Neuromuscular patients with acute respiratory failure require protocolized and personalized triage and treatment. Here, we describe the technical methods used at our single institution. The triage phase incorporates comprehensive evaluation for new etiologies of hypoxia and hypercapnia, which are not initially presumed to be secondary to progression or end-stage neuromuscular respiratory failure. In select patients, this may involve intubation or advanced adjustments of NIV machines. Next, once the acute etiology(s) is identified and treated, the focus shifts: training and use of mechanical airway clearance to optimize pulmonary function, facilitation of NIV wean or successful extubation to NIV, and transition to a stable regimen for home ventilation. The comprehensive protocol described here incorporates multi institutional approaches and effectively optimizes acute respiratory failure in patients with neuromuscular pulmonary disease.
- 1 April 2013
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 34 (2-3) , 350-359
SLC17: A functionally diverse family of organic anion transporters
- 1 April 2013
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 34 (2-3) , 350-359
SLC17: A functionally diverse family of organic anion transporters
- Open Access
- 1 June 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (25) , 19316-19323
Structure-Function Studies of the SLC17 Transporter Sialin Identify Crucial Residues and Substrate-induced Conformational Changes
- 1 June 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (25) , 19316-19323
Open AccessStructure-Function Studies of the SLC17 Transporter Sialin Identify Crucial Residues and Substrate-induced Conformational Changes
- Open Access
- 27 January 2010
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 30 (4) , 1288-1300
Glutamine Is Required for Persistent Epileptiform Activity in the Disinhibited Neocortical Brain Slice
The neurotransmitter glutamate is recycled through an astrocytic–neuronal glutamate–glutamine cycle in which synaptic glutamate is taken up by astrocytes, metabolized to glutamine, and transferred to neurons for conversion back to glutamate and subsequent release. The extent to which neuronal glutamate release is dependent upon this pathway remains unclear. Here we provide electrophysiological and biochemical evidence that in acutely disinhibited rat neocortical slices, robust release of glutamate during sustained epileptiform activity requires that neurons be provided a continuous source of glutamine. We demonstrate that the uptake of glutamine into neurons for synthesis of glutamate destined for synaptic release is not strongly dependent on the system A transporters, but requires another unidentified glutamine transporter or transporters. Finally, we find that the attenuation of network activity through inhibition of neuronal glutamine transport is associated with reduced frequency and amplitude of spontaneous events detected at the single-cell level. These results indicate that availability of glutamine influences neuronal release of glutamate during periods of intense network activity.
- 27 January 2010
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 30 (4) , 1288-1300
Open AccessGlutamine Is Required for Persistent Epileptiform Activity in the Disinhibited Neocortical Brain Slice
The neurotransmitter glutamate is recycled through an astrocytic–neuronal glutamate–glutamine cycle in which synaptic glutamate is taken up by astrocytes, metabolized to glutamine, and transferred to neurons for conversion back to glutamate and subsequent release. The extent to which neuronal glutamate release is dependent upon this pathway remains unclear. Here we provide electrophysiological and biochemical evidence that in acutely disinhibited rat neocortical slices, robust release of glutamate during sustained epileptiform activity requires that neurons be provided a continuous source of glutamine. We demonstrate that the uptake of glutamine into neurons for synthesis of glutamate destined for synaptic release is not strongly dependent on the system A transporters, but requires another unidentified glutamine transporter or transporters. Finally, we find that the attenuation of network activity through inhibition of neuronal glutamine transport is associated with reduced frequency and amplitude of spontaneous events detected at the single-cell level. These results indicate that availability of glutamine influences neuronal release of glutamate during periods of intense network activity.
- Open Access
- 9 December 2009
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (49) , 15355-15365
The Lysosomal Sialic Acid Transporter Sialin Is Required for Normal CNS Myelination
Salla disease and infantile sialic acid storage disease are autosomal recessive lysosomal storage disorders caused by mutations in the gene encoding sialin, a membrane protein that transports free sialic acid out of the lysosome after it is cleaved from sialoglycoconjugates undergoing degradation. Accumulation of sialic acid in lysosomes defines these disorders, and the clinical phenotype is characterized by neurodevelopmental defects, including severe CNS hypomyelination. In this study, we used a sialin-deficient mouse to address how loss of sialin leads to the defect in myelination. Behavioral analysis of thesialin−/−mouse demonstrates poor coordination, seizures, and premature death. Analysis by histology, electron microscopy, and Western blotting reveals a decrease in myelination of the CNS but normal neuronal cytoarchitecture and normal myelination of the PNS. To investigate potential mechanisms underlying CNS hypomyelination, we studied myelination and oligodendrocyte development in optic nerves. We found reduced numbers of myelinated axons in optic nerves fromsialin−/−mice, but the myelin that was present appeared grossly normal. Migration and density of oligodendrocyte precursor cells were normal; however, a marked decrease in the number of postmitotic oligodendrocytes and an associated increase in the number of apoptotic cells during the later stages of myelinogenesis were observed. These findings suggest that a defect in maturation of cells in the oligodendrocyte lineage leads to increased apoptosis and underlies the myelination defect associated with sialin loss.
- 9 December 2009
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (49) , 15355-15365
Open AccessThe Lysosomal Sialic Acid Transporter Sialin Is Required for Normal CNS Myelination
Salla disease and infantile sialic acid storage disease are autosomal recessive lysosomal storage disorders caused by mutations in the gene encoding sialin, a membrane protein that transports free sialic acid out of the lysosome after it is cleaved from sialoglycoconjugates undergoing degradation. Accumulation of sialic acid in lysosomes defines these disorders, and the clinical phenotype is characterized by neurodevelopmental defects, including severe CNS hypomyelination. In this study, we used a sialin-deficient mouse to address how loss of sialin leads to the defect in myelination. Behavioral analysis of thesialin−/−mouse demonstrates poor coordination, seizures, and premature death. Analysis by histology, electron microscopy, and Western blotting reveals a decrease in myelination of the CNS but normal neuronal cytoarchitecture and normal myelination of the PNS. To investigate potential mechanisms underlying CNS hypomyelination, we studied myelination and oligodendrocyte development in optic nerves. We found reduced numbers of myelinated axons in optic nerves fromsialin−/−mice, but the myelin that was present appeared grossly normal. Migration and density of oligodendrocyte precursor cells were normal; however, a marked decrease in the number of postmitotic oligodendrocytes and an associated increase in the number of apoptotic cells during the later stages of myelinogenesis were observed. These findings suggest that a defect in maturation of cells in the oligodendrocyte lineage leads to increased apoptosis and underlies the myelination defect associated with sialin loss.
- Open Access
- 1 March 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (13) , 8439-8448
Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport
- 1 March 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (13) , 8439-8448
Open AccessSynaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport
- 1 March 2008
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 168 (2) , 306-319
Imaging of glutamate in brain slices using FRET sensors
- 1 March 2008
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 168 (2) , 306-319
Imaging of glutamate in brain slices using FRET sensors
- 1 January 2008
- Published by Springer Nature
- p. 263-295
Neurotransmitter Reuptake and Synaptic Vesicle Refilling
- 1 January 2008
- Published by Springer Nature
- p. 263-295
Neurotransmitter Reuptake and Synaptic Vesicle Refilling